跳至主要内容

LC-MS/MS Method Development

 

What Is LC-MS?

(LC) Liquid Chromatography:

Chromatography is a separations method that relies on differences in partitioning behavior between a flowing mobile phase and a stationary phase to separate the the components in a mixture.
A column holds the stationary phase and the mobile phase carries the sample through it.
Sample components that partition strongly into the stationary phase spend a greater amount of time in the column and are separated from components that stay predominantly in the mobile phase and pass through the column faster.

(MS) Mass Spectrometry:

Mass spectrometers use the difference in mass-to-charge ratio (m/z) of ionized compounds to separate them from each other.

Compounds have distinctive fragmentation patterns that provide structural information to specifically detect compounds.

(MS) Mass Spectrometry

Types of Mass Spectrometers

• LC-MS (Single Quadrupole)
• LC-MS/MS (Triple Quadrupoles)
• LC-Q (Ion Traps, Linear Ion Traps)
• LC-Q-TRAPS (Quadrupole Linear Ion Traps)
• LC-TOF-MS (Time-of-Flight)
• MALDI-TOF-MS
• Q-TOF-MS (Quadrupole Time-of-Flight)
• FT-MS (Fourier Transform)
• Others

 

LC-MS/MS (Triple Quadrupole)

The instrument can be used for quantification and identification of known biological and chemical molecules in complex extracts and mixtures.

The sum of all these instruments represents a multipurpose and efficient MS centre due to its adaptability. Versatility of the facility refers not only to Ionization modes ( ESI, APCI, APPI, ASAP and EI), but also to diversity of separation technologies available like UPC2 (SCF chromatography), UPLC, GC and Ion Chromatography. Therefore a large number of different chemical compounds can be separated and identified in this facility.

LC/MS/MS Advantages

  • Can be the most sensitive method for protein ID (The smaller the column the more sensitive)
  • Unambiguous search results (Very few false positives)
  • Only a single peptide is required for ID
  • The ability to perform limited homology searches single substitution within a peptide
  • Able to ID proteins from simple mixtures (~20) such as immunoprecipitates
  • The data can be searched against EST databases

 

LC/MS/MS Disadvantages

  • Time (Both acquisition and analysis)
  • Chromatography problems of NanoLC

The LC-MS/MS method development can be separated into two parts: sample extraction method development and LC-MS/MS instrument method development.

 

Sample Extraction Method Development

A sample extraction step may be performed using protein precipitation (PPT), liquid-liquid extraction (LLE), or solid-phase extraction (SPE) methods. PPT is a commonly used sample extraction method, especially in the drug discovery stage. It is a fast, easy-to-apply method for small molecule analysis. The drawback of PPT is that it is not a selective method like LLE or SPE, so matrix effect or ion interference may be observed in chromatograms. LLE is the other widely used sample extraction method. It can be developed as a specific method and can generate clean sample extract solutions.

Another sample extraction method, the SPE method, separates analytes in a chromatographic way and generates a cleaner resultant solution. Extract solution prepared by LLE and SPE methods are more suitable for ultra high performance liquid chromatography (UHPLC) analysis. All three sample extraction methods can be transferred to robotic systems to increase sample preparation efficiency.

LC-MS/MS Instrument Method Development

LC-MS/MS instrument method development requires appropriate settings of LC system and MS system. For LC system setup, mobile phase, LC column, gradient, flow rate, and column temperature are the most commonly adjusted factors based on method development time, analysis run time, and expected number of samples per day.

The purpose of method development is to establish a fast, reliable method which can provide clear resolution of the analyte(s). For MS system setup, ion source parameters, mass transitions monitored in multiple reactions monitoring (MRM), and collision cell parameters are commonly-adjusted factors based on expected analyte concentration and response. The goal of adjustment is to optimize MRM transition response while remaining free of interference. The LC-MS/MS methods developed by our bioanalytical team offer expedited, sensitive, and isotopic-specific results of the analytes. LC-MS/MS method validation is necessary to obtain reliable data during new drug development. A well-developed and validated method is often used from drug development to post-marketing surveillance.

Related Articles:

LC-MS Analysis Service

LC-MS Method Development and Validation

LC-MS/MS Method Development

评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

Enzyme Activity Assay Service

  Enzymatic assay Lance Assay Alphascreen Assay Z’-LYTE Assay Adapta Assay Kinase-Glo Assay ADP-Glo Assay Ligand Binding Assay ELISA Assay HTRF Assay Enzyme activity assays  are laboratory methods for measuring enzymatic activity. They are vital for the study of enzyme kinetics and enzyme inhibition. Enzyme units : Amounts of enzymes can either be expressed as molar amounts, as with any other chemical, or measured in terms of activity, in enzyme units. Medicilon provides various  enzyme activity assays  for  kinases , phosphatases, proteinases, deacetylase, peptidase, esterase, and other enzymes. Our line of well-characterized immunoassays and biochemical kits ensures accurate and reproducible results. Enzyme is a  large category of bio-molecules  that catalyze various biological processes including metabolic processes, cellular signaling and regulation, cell division and apoptosis. Enzymatic reactions convert substrate molecules into chemically modified molecules products with high sp